指南与共识类风湿关节炎

难治性类风湿关节炎药物与非药物治疗策略的系统文献综述:为EULAR管理建议提供依据

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis.
指南 / 共识 · RMD Open · 2021-01-01

研究发现,在既往失败生物制剂(bDMARDs)的患者中,所有当前使用的b/tsDMARDs均比安慰剂有效;既往失败TNFi者,非TNFi bDMARDs有更有效的趋势;既往失败bDMARDs数量越多,疗效越低。非药物干预可改善非炎症性主诉、目标设定和自我管理。

要点

  • 既往失败bDMARDs数量越多,后续b/tsDMARDs疗效越低。
  • 既往失败TNFi者,非TNFi bDMARDs有更有效的趋势。
  • 非药物干预可改善功能残疾、疼痛、疲劳、目标设定和自我管理。

核心结论

  • D2T RA药物与非药物治疗的高质量证据稀缺。
  • b/tsDMARDs疗效随既往失败bDMARDs数量增加而降低,换用不同作用机制的b/tsDMARDs可能更有效。
  • 非药物干预对改善非炎症性主诉、目标设定和自我管理有益。

研究设计与样本

  • 共纳入207篇研究治疗策略的论文。

主要发现

  • 在既往失败bDMARDs的患者中,所有当前使用的b/tsDMARDs均比安慰剂有效。
  • 在既往失败TNFi的患者中,非TNFi bDMARDs有比TNFi更有效的趋势。
  • 一般来讲,既往失败bDMARDs数量更多的患者疗效下降。
  • 运动、心理、教育和自我管理干预可改善非炎症性主诉(主要是功能残疾、疼痛、疲劳)。
  • 教育可改善目标设定,自我管理项目、教育和心理干预可改善自我管理。

关键数值与推荐

  • 在合并症和其他禁忌症限制DMARD选择(肥胖、乙型和丙型肝炎、静脉血栓栓塞风险、妊娠和哺乳)的患者中,有效且安全的DMARDs证据有限。
  • 未发现专门针对D2T RA患者的研究。
  • 研究使用的结局标准异质,且多数研究存在中或高偏倚风险。

临床怎么用

  • 对既往失败bDMARDs数量较多的RA患者,换用不同作用机制的b/tsDMARDs可能更有效。
  • 非药物干预可用于改善D2T RA患者的非炎症性主诉、目标设定和自我管理。

局限性

  • 未发现专门针对D2T RA患者的研究。
  • 研究使用的结局标准异质。
  • 多数研究存在中或高偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To summarise, by a systematic literature review (SLR), the evidence regarding pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis (D2T RA), informing the EULAR recommendations for the management of D2T RA. METHODS: PubMed, Embase and Cochrane databases were searched up to December 2019. Relevant papers were selected and appraised. RESULTS: Two hundred seven (207) papers studied therapeutic strategies. Limited evidence was found on effective and safe disease-modifying antirheumatic drugs (DMARDs) in patients with comorbidities and other contraindications that limit DMARD options (patients with obesity, hepatitis B and C, risk of venous thromboembolisms, pregnancy and lactation). In patients who previously failed biological (b-)DMARDs, all currently used b/targeted synthetic (ts-)DMARDs were found to be more effective than placebo. In patients who previously failed a tumour necrosis factor inhibitor (TNFi), there was a tendency of non-TNFi bDMARDs to be more effective than TNFis. Generally, effectiveness decreased in patients who previously failed a higher number of bDMARDs. Additionally, exercise, psychological, educational and self-management interventions were found to improve non-inflammatory complaints (mainly functional disability, pain, fatigue), education to improve goal setting, and self-management programmes, educational and psychological interventions to improve self-management.The identified evidence had several limitations: (1) no studies were found in patients with D2T RA specifically, (2) heterogeneous outcome criteria were used and (3) most studies had a moderate or high risk of bias. CONCLUSIONS: This SLR underscores the scarcity of high-quality evidence on the pharmacological and non-pharmacological treatment of patients with D2T RA. Effectiveness of b/tsDMARDs decreased in RA patients who had failed a higher number of bDMARDs and a subsequent b/tsDMARD of a previously not targeted mechanism of action was somewhat more effective. Additionally, a beneficial effect of non-pharmacological interventions was found for improvement of non-inflammatory complaints, goal setting and self-management.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Roodenrijs NMT, Hamar A, Kedves M, et al. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open. 2021. PMID: 33419871. doi:10.1136/rmdopen-2020-001512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。